Search filters

List of works by Barney S. Graham

2904. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice

scholarly article by Brett W Jagger et al published 23 October 2019 in Open Forum Infectious Diseases

A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus

scientific article (publication date: 2015)

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

scientific article

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

scientific article

A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology

scientific article

A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8+ Memory T Cells

scientific article published on 11 January 2019

A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats

scientific article published on 08 June 2016

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

scientific article

A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.

scientific article published in January 2000

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

scientific article published on 26 September 2008

A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply

scientific article published on 19 August 2020

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

scientific article

A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes

scientific article published on 21 September 2016

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

scientific article (publication date: 15 December 2007)

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial ⬇️

scientific article published on March 11, 2011

A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice

scientific article published on 26 January 2022

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

scientific article published in August 1999

A filovirus-unique region of Ebola virus nucleoprotein confers aberrant migration and mediates its incorporation into virions

scientific article

A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate ⬇️

scientific article published on August 19, 2010

A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry

scientific article published on 20 November 2018

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

scientific article

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

scientific article

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

scientific article (publication date: 2011)

A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone

scientific article published on 23 October 2020

A proof of concept for structure-based vaccine design targeting RSV in humans

scientific article published on 01 August 2019

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

scientific article published on 27 October 2010

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage

scientific article published on 22 September 2017

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

scientific article published on 28 May 2019

A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection

scientific article published on 01 February 2019

Abstracts of AIDS Vaccine 2009. Paris, France. October 19-22, 2009

article

Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin

scientific article published on 23 July 2019

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus

scientific article published on 26 October 2017

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

scientific article published in April 1997

Adult immunization with acellular pertussis vaccine

scientific article published on 01 January 1993

Advances in antiviral vaccine development

scientific article published on September 2013

Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent

scientific article

Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease

scientific article

An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model

scientific article published on 27 November 2020

An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

scientific article published in June 2017

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

scientific article published on 14 July 2020

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

scientific article published in February 1998

Animal models for COVID-19

scientific article published on 23 September 2020

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

scientific article

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

scientific article published on 01 November 2019

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

scholarly article by Nicole Doria-Rose published in 2021

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

scientific article published on 8 March 2021

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia

scientific article

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

scientific article published on 01 November 2019

Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers

scientific article published on November 2003

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

scientific article published on 05 November 2018

Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F

scientific article

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

scientific article published on 21 February 2017

Attenuated activation of pulmonary immune cells in mRNA-1273–vaccinated hamsters after SARS-CoV-2 infection

scientific article published in 2021

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published in March 1993

Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

scientific article published on 01 June 2019

Author Correction: Next-generation influenza vaccines: opportunities and challenges

scientific article published on 01 June 2020

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

scientific article

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials

scientific article

Binding of human immunodeficiency virus type 1 to the C3b/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks

scientific article published in August 1994

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development ⬇️

scientific article published on January 1, 2011

Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen

article

Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160

scientific article published on 29 July 2004

Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.

scientific article

Broad neutralization of SARS-related viruses by human monoclonal antibodies

scientific article published on 15 June 2020

Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein

scientific article published on 16 May 2020

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype ⬇️

scientific article

CD8+ TCR transgenic strains expressing public versus private TCR targeting the respiratory syncytial virus K(d)M2(82-90) epitope demonstrate similar functional profiles

scientific article

Candidate AIDS vaccines

scientific article

Challenges and opportunities for respiratory syncytial virus vaccines

scientific article published on January 2013

Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop

scientific article

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

scientific article published on 10 July 2015

Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus

scientific article published on 08 May 2020

Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model

scientific article published on 04 March 2009

Chikungunya in the Americas: Recommendations and Conclusions

scientific article published on December 2016

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

scientific article

Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report

scientific article published in August 2015

Chronic fibrosing mediastinitis and superior vena caval obstruction from blastomycosis

scientific article published on 01 October 1992

Clinical trials of AIDS vaccines in seronegative volunteers: vectors and combinations

scientific article published on 01 August 1992

Clinical trials of HIV vaccines.

scientific article

Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses.

scientific article published on 8 February 2014

Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar ⬇️

scholarly article by Reham A Al Kahlout et al published 2019 in Journal of Immunology Research

Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus

scientific article published in January 2014

Comparison of adjuvants to optimize influenza neutralizing antibody responses

scientific article published on 05 September 2019

Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

scientific article published on 25 May 2020

Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine

scientific article published in September 2001

Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection

scientific article published on January 2004

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

scientific article published on May 2009

Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state

scientific article published on 29 November 2017

Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

scientific article published in June 2016

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

scientific article

Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions

publication published on 21 May 2021

Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions

scientific article published on 20 December 2020

Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation

scientific article published on 16 February 2020

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

scientific article published on 19 February 2020 in Science

Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B

scientific article published on 11 December 2019

Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms

scientific article published on 01 January 2005

Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice

scientific article published on 01 August 2000

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

scientific article published in February 1998

DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies

article

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials ⬇️

scientific article published on 03 October 2011

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

scientific article published on 7 May 2015

DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults

scientific article

DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes

scientific article published on 01 December 2019

DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial

scientific article

DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial

scientific article published in PLoS ONE

DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases

scientific article published on September 2009

Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus

scientific article

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

scientific article published on 26 February 2019

Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus

scientific article published in April 1997

Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network

scientific article

Determinants of early life immune responses to RSV infection

scientific article

Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins

article

Development of a potent Zika virus vaccine using self-amplifying messenger RNA

scientific article published on 07 August 2020

Development of an AIDS vaccine. Biological and ethical challenges

scientific article published on June 1990

Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees ⬇️

scientific article published on May 1, 1993

Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization

scientific article published in January 2010

Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab

scientific article

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

scientific article published on 01 June 2020

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

scientific article published on 03 December 2020

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

scientific article

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

scientific article

Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques

scientific article published on 21 March 2016

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

scientific article

Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial

scientific article published on 01 April 2020

Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection

scientific article

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

scientific article published on 2 September 2015

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

scientific article published on 30 December 2020

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas

scholarly article by Danielle Adney et al published 2 March 2019 in Viruses

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

scientific article

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

scientific article

Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic

scientific article

Endocarditis and infections of intravascular devices due to Eikenella corrodens

scientific article published on 01 October 1986

Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.

scientific article

Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo

scientific article

Epitope-Specific Regulatory CD4 T Cells Reduce Virus-Induced Illness while Preserving CD8 T-Cell Effector Function at the Site of Infection ⬇️

scientific article published on August 4, 2010

Epitope-Specific Serological Assays for RSV: Conformation Matters

scientific article published on 23 February 2019

Evaluation of candidate vaccine approaches for MERS-CoV.

scientific article published on 28 July 2015

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

scientific article published on 28 July 2020

Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States

scientific article published on 25 February 2009

Extrapulmonary thoracic disease caused by Blastomyces dermatitidis

scientific article published on 01 December 1994

Fc Glycan-Mediated Regulation of Placental Antibody Transfer

scientific article published on 13 June 2019

Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

scientific article published on 05 February 2014

Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients

scientific article

Functional interrogation and mining of natively paired human VH:VL antibody repertoires

scientific article published on 8 January 2018

Future Opportunities for Passive Immunity Against Viral Diseases ⬇️

scientific article published on October 12, 2011

GM-CSF Production Allows the Identification of Immunoprevalent Antigens Recognized by Human CD4+ T Cells Following Smallpox Vaccination ⬇️

scientific article published on September 9, 2011

Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation

scientific article published on 10 June 2013

Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus

scientific article published on 25 September 2019

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

scientific article published on 07 February 2020

H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.

scientific article published on 15 June 2015

HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques

scientific article published on 09 August 2017

HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission

scientific article (publication date: April 2014)

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

scientific article published on 30 July 2015

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 November 1994

HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.

scientific article

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

scientific article

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

scientific article

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

scientific article

Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis

scientific article

High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination

scientific article published on 18 March 2009

High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity

scientific article published on 28 November 2019

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

scientific article published on 12 February 2017

History of passive antibody administration for prevention and treatment of infectious diseases

scientific article published on May 2015

Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial

scientific article

Human amniotic fluid antibodies protect the neonate against respiratory syncytial virus infection

scientific article published on 16 June 2016

Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies

scientific article published in March 2006

Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates

scientific article published on 11 February 2020

IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse

scientific article published on 24 October 2006

IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge

scientific article published on February 2003

IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo

scientific article published on 01 April 2000

Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus

scientific article

Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus

scientific article published in April 2002

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

scientific article

Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges

scientific article published on 13 November 2001

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

scientific article published in May 1998

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity

scientific article (publication date: 10 August 2010)

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

scientific article published in February 1996

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

scientific article

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.

scientific article published on 14 August 2017

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

scientific article published on 01 September 2019

Immunological goals for respiratory syncytial virus vaccine development

scientific article published on 25 April 2019

Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

scientific article published in August 1993

Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape

scientific article published on 7 March 2018

Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.

scientific article published on 24 May 2017

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

article published in 2021

Increased detection of herpesvirus DNA in idiopathic pulmonary fibrosis

scientific article published in July 2001

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans

scientific article published on 17 September 2007

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation

scientific article published on 20 January 2018

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants

scientific article

Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant

scientific article

Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans ⬇️

scientific article published on September 5, 2012

Influenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem

scientific article published on 12 March 2020

Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.

scientific article published on 14 July 2004

Interleukin-12 Treatment during Immunization Elicits a T Helper Cell Type 1-like Immune Response in Mice Challenged with Respiratory Syncytial Virus and Improves Vaccine Immunogenicity ⬇️

scientific article published on September 1, 1995

Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo

scientific article

Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials Group

scientific article published on 01 October 1994

Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.

scientific article published on 25 May 2016

Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses

scientific article

Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem

scientific article

Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.

scientific article published on August 2016

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

scientific article published on 01 October 2020

Lessons from failure--preparing for future HIV-1 vaccine efficacy trials

scientific article published on 27 January 2005

Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans

scientific article published in 2021

Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses

scientific article published on 10 March 2017

Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo

scientific article

Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

scientific article (publication date: 9 May 2008)

Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 ⬇️

scientific article published on June 29, 2011

Memory Inflation Drives Tissue-Resident Memory CD8 T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus

article by Kaitlyn M Morabito et al published 2018 in Frontiers in Immunology

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

scientific article published on 31 August 2020

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

scientific article published on 8 January 2018

Modified vaccinia Ankara: potential as an alternative smallpox vaccine

scientific article published on 19 May 2004

Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.

scientific article

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

scientific article published on 11 February 2019

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination

scientific article

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

scientific article published on 13 September 2012

Mutations in the spike protein of MERS-CoV transmitted in Korea increase resistance towards antibody-mediated neutralization

scientific article published on 04 January 2019

NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus

scientific article

Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice

scientific article published on December 2011

Neonatal mice possess two phenotypically and functionally distinct lung-migratory CD103(+) dendritic cell populations following respiratory infection

scientific article published on 5 April 2017

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 August 1994

New approaches to vaccine adjuvants: inhibiting the inhibitor

scientific article

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

scientific article

Next-Generation Influenza Vaccines

scientific article published on 30 March 2020

Next-generation influenza vaccines: opportunities and challenges

scientific article published on 14 February 2020

Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases

scientific article published on 22 March 2018

Novel antigens for RSV vaccines

scientific article

Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes

scientific article

OMIP-061: 20-Color Flow Cytometry Panel for High-Dimensional Characterization of Murine Antigen-Presenting Cells

scientific article published on 19 August 2019

Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus ⬇️

scientific article published on November 1, 1997

P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011).

scientific article published on 22 October 2009

P14-12. Safety and tolerability of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular, subcutaneous and intradermal administration in healthy adults

scientific article published on 22 October 2009

P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation

scientific article (publication date: 2009)

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen

article

P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys

article

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.

scientific article published on 31 August 2016

Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus

scientific article published in October 1999

Pathogenesis of respiratory syncytial virus infection in the murine model

scientific article

Pathogenesis of respiratory syncytial virus vaccine-augmented pathology

scientific article published on October 1995

Perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention ⬇️

scientific article published on September 1, 1992

Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection

scientific article published on 5 September 2000

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

scientific article published on 8 November 2006

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

scientific article published on 8 November 2006

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

scientific article

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

scientific article published on February 2007

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

scientific article published on 07 March 2007

Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost

scientific article published on 11 August 2015

Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)

scientific article

Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-Dependent

scientific article published on 11 January 2016

Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination

scientific article

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.

scientific article published on 13 February 2017

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus.

scientific article published on 29 September 2016

Pre-fusion structure of a human coronavirus spike protein.

scientific article

Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans

scientific article published on July 2017

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera

scientific article

Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine

scientific article published on 01 April 2019

Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes

scientific article published on December 2004

Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus ⬇️

scientific article published on January 28, 2011

Primary respiratory syncytial virus infection in mice

scientific article

Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect

scientific article published on 30 April 2013

Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus

scientific article published in August 1993

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

scientific article (publication date: 2 February 2010)

Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge ⬇️

scientific article published on April 1, 1998

Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans

scientific article published on 4 October 2017

Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine

scientific article published on 22 September 2014

Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection

scientific article published in September 2004

Proof of principle for epitope-focused vaccine design

scientific article

Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge

scientific article published in September 1999

Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

publication published on 01 June 2021

Protecting the family to protect the child: vaccination strategy guided by RSV transmission dynamics

scientific article published on 12 February 2014

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

scientific article (publication date: 9 May 2016)

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine

scientific article

Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice

scientific article published on 01 October 2019

Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo

scientific article published in May 1996

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

scientific article

Prototype pathogen approach for pandemic preparedness: world on fire

scientific article published on 30 April 2020

Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

scientific article published in Scientific Reports

Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates

scientific article

Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein

scientific article published on 2 June 2008

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

article

Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response

scientific article

RSV neutralizing antibodies at birth predict protection from RSV illness in infants in the first three months of life

scientific article published on 28 May 2020

Rapid COVID-19 vaccine development

scientific article published on 08 May 2020

Rapid development of a DNA vaccine for Zika virus

scientific article

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

scientific article published on 09 December 2016

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

scientific article published on 12 August 2015

Recent progress in immune-based interventions to prevent HIV-1 transmission to children

scientific article published in December 2017

Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike

scientific article published on 31 March 2018

Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities

scientific article published on 19 January 2009

Reinfection of mice with respiratory syncytial virus

scientific article published on May 1991

Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection

scientific article

Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials

scientific article published on April 2009

Reply

Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

scientific article

Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV.

scientific article published on 4 August 2000

Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003.

scientific article

Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.

scientific article

Respiratory syncytial virus immunobiology and pathogenesis

scientific article

Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5.

scientific article published on 6 May 2004

Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice

scientific article published in February 2001

Respiratory syncytial virus infection in anti-mu-treated mice

scientific article published on September 1991

Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels

scientific article

Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice

scientific article published in February 1999

Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics

scientific article published on 25 January 2018

Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease

scientific article published on January 2013

Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope

scientific article

RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology

scientific article

RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G

scientific article published on May 2004

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

scientific article

Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation

scientific article

SARS-CoV-2 Viral Variants—Tackling a Moving Target

scientific article

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

scientific article published on 11 June 2020

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

scientific article published on 05 August 2020

Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group ⬇️

scientific article published on September 20, 1997

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

scientific article published on 29 September 2020

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

scientific article

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)

scientific article

Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial ⬇️

scientific article published on September 12, 2011

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

scientific article published on 15 April 2019

Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial

scientific article

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

scientific article

Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group

scientific article published in May 1996

Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects

scientific article published on April 2007

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group

scientific article published on 01 August 1996

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

scientific article

Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.

scientific article published in December 1993

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.

scientific article

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)

scientific article

Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial

scientific article published on 18 September 2019

Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection ⬇️

scientific article

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa

scientific article (publication date: 21 September 2010)

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

scientific article published on 28 August 2019

Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.

scientific article published on 24 January 2018

Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections

scientific article published in May 1995

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

scientific article published on 14 August 2014

Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 January 1994

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

scientific article published on 4 November 2019

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals

scientific article published on 7 November 2006

Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults

scientific article published on September 2015

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

scientific article published on 14 November 2017

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

scientific article published on 4 December 2017

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

article by Martin R Gaudinski et al published 2 March 2019 in The Lancet

Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.

scientific article

Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice

scientific article published in April 2002

Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses

scientific article

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses

scientific article published on 23 June 2020

Serological responses to candidate AIDS vaccines

scientific article published on January 1994

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

scientific article published on 17 February 2021

Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.

scientific article published on June 1986

Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection.

scientific article published on August 1986

Serum vitamin A levels in respiratory syncytial virus infection

scientific article published in March 1994

Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020

scientific article published on 03 July 2020

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

scientific article published on 17 November 2017

Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness

scientific article published on October 2004

Smallpox vaccines: Past, present, and future

scientific article published on December 2006

Specific activation strategies for amplification of low CTL signals

scientific article published on 01 August 1992

Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

scientific article published in Scientific Reports

Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus

scientific article published in April 1988

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

scientific article published on 29 April 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

scientific article published on 01 June 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

scientific article (preprint)

Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD

scientific article published on 01 September 2019

Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex

scientific article

Structural and molecular basis for Ebola virus neutralization by protective human antibodies

scientific article

Structural basis of respiratory syncytial virus neutralization by motavizumab

scientific article

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

scientific article published on 30 November 2017

Structure of MERS-Coronavirus Spike Receptor-binding Domain (England1 Strain) in Complex with Vaccine-Elicited Murine Neutralizing Antibody D12 (Crystal Form 2)

article

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

scientific article

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes

scientific article

Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F

scientific article published in December 2010

Structure of unbound MERS-CoV spike receptor-binding domain (England1 strain)

article

Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development

scientific article published on 11 June 2020

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

scientific article

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

scientific article published on 23 June 2020

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

scientific article published on 21 July 2020

Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes ⬇️

scientific article published on 12 October 2020

Structure-Based Vaccine Antigen Design

scientific article published on 01 January 2019

Structure-based design of head-only fusion glycoprotein immunogens for respiratory syncytial virus

scientific article

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

scientific article

Subtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4(+) T cells

scientific article

Subunit recombinant vaccine protects against monkeypox

scientific article published on August 2006

T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection.

scientific article

T cell immunity to SARS-CoV-2 following natural infection and vaccination

scientific article published on 23 October 2020

T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice

scientific article published on May 1997

TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity

scientific article published on 03 April 2009

Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

scientific article published on 04 August 2020

Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.

scientific article published on 14 December 2011

The Complex Relationship between Respiratory Syncytial Virus and Allergy in Lung Disease ⬇️

scientific article published on January 1, 2003

The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography

scientific article published on 20 August 2018

The Zika virus envelope protein glycan loop regulates virion antigenicity

scientific article published on 2 January 2018

The histopathology of fatal untreated human respiratory syncytial virus infection

scientific article

The immune space: a concept and template for rationalizing vaccine development

scientific article

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

scientific article

The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors ⬇️

scientific article published on December 17, 2010

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

scholarly article by Natalie I Mazur et al published October 2018 in Lancet Infectious Diseases

The role of IFN in respiratory syncytial virus pathogenesis

scientific article published in March 2002

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

scientific article published in January 1991

Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire

scientific article published on 12 March 2013

Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant.

scientific article

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects

scientific article published on 21 September 2011

Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin

scientific article

Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways

scientific article

Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection

scientific article published on March 2004

Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection

scientific article published on 14 February 2020

Trypsin treatment unlocks barrier for zoonotic coronaviruses infection

scientific article published on 17 September 2019

Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens.

scientific article published on 16 February 2018

Update on policy change proposal to end Institutional Biosafety Committee (IBC) review of rDNA vaccine clinical trials

scientific article published on 13 September 2012

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

scientific article

Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera.

scientific article

V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Tria

scientific article

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

scientific article

Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge

scientific article published in PLoS ONE

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

scientific article published on August 1, 1992

Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles

scientific article

Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge

scientific article published in September 1999

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

scientific article

Vaccine development for respiratory syncytial virus

scientific article

Vaccine development in the twenty-first century: changing paradigms for elusive viruses

scientific article

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

scientific article

Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccines

scientific article published on 01 April 1997

Vaccines against respiratory syncytial virus: The time has finally come

scientific article published on 13 May 2016

Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance

scientific article published on 25 April 2020

Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV

scientific article

Viral and host factors in human respiratory syncytial virus pathogenesis

scientific article

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

scientific article published on December 2015

Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses.

scientific article published on 3 November 2016

Vitamin A therapy for respiratory syncytial virus infection

scientific article published in January 1997

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use

scientific article published in February 2022

What does the report of the USMHRP Phase III study in Thailand mean for HIV and for vaccine developers?

scientific article published on 01 December 2009

Whither monkeypox vaccination ⬇️

scientific article published on December 19, 2011

Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus

scientific article

Zika Virus Vaccine Development

scientific article

Zika Virus: Immunity and Vaccine Development

scientific article

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

scientific article

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

scholarly article by Kizzmekia Corbett et al published 20 August 2021 in Nature Immunology

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants

scientific article published on 25 January 2021

rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses

scientific article published on 13 September 2012

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1.

scientific article published on 13 September 2012

Paulina is supported by:

About Paulina

Help